COREG CR

Indicated For

Heart failure, hypertension, left ventricular dysfunction following myocardial infarction

About This Medication

# Waylis Patient Access and Affordability Program Patient Guide: How to Get COREG CR (carvedilol phosphate) at Low or No Cost COREG CR (carvedilol phosphate) is an **extended-release beta-blocker** used to treat **heart failure**, **high blood pressure (hypertension)**, and **left ventricular dysfunction** after a heart attack in adults. This guide explains the **Waylis Patient Access and Affordability Program**, which helps eligible **uninsured** or **Medicare/government-insured patients** get COREG CR at low or no cost if your household income is at or below **250% of the Federal Poverty Level (FPL)**. ## Who Qualifies for the Program? The program is designed for patients facing financial barriers to COREG CR. **Key eligibility criteria** include: - **U.S. residency** (including territories like Puerto Rico). - **Valid prescription** from a U.S.-licensed healthcare provider. - **Household income** at or below **250% FPL** (specific to uninsured or Medicare patients; note that some Waylis programs use higher thresholds like 500% FPL for other drugs, but COREG CR follows 250%). - **Insurance status**: Uninsured or enrolled in Medicare/government insurance (e.g., Medicare Part D, Medicaid, TRICARE). **Commercially insured patients** may have separate copay options, but this PAP focuses on uninsured/Medicare. - **No participation** in certain federal programs that prohibit assistance (check with program for details). **Important**: You must be 18+ or have a legal guardian apply. The program prohibits healthcare providers from charging patients for the medication. ## About COREG CR (carvedilol phosphate) **COREG CR** is a once-daily, extended-release capsule form of carvedilol, a non-selective beta-blocker with alpha-1 blocking activity. It works by: - Slowing the heart rate and reducing blood pressure. - Decreasing the heart's workload in **heart failure**. - Improving survival after **myocardial infarction (heart attack)** with reduced ejection fraction. **Common uses**: - **Hypertension**: Lowers blood pressure to reduce stroke/heart attack risk. - **Heart failure**: Improves symptoms and quality of life. - **Post-heart attack**: Prevents further heart damage. **Key facts**: - Available strengths: 10 mg, 20 mg, 40 mg, 80 mg extended-release capsules. - Taken once daily with food to improve absorption. - **Do not stop suddenly** without doctor advice, as it may worsen heart conditions. **Common side effects**: Dizziness, fatigue, low blood pressure, slow heart rate, weight gain. **Serious risks**: Worsening heart failure, bronchospasm (avoid in asthma/COPD), severe bradycardia. Always follow your doctor's instructions and report side effects to FDA at 1-800-FDA-1088. **Disclaimer**: This guide provides general information. COREG CR requires medical supervision. Consult your healthcare provider for personalized advice. Waylis Therapeutics does not guarantee eligibility or supply. ## Income Eligibility Breakdown Eligibility is based on **annual household gross income** at or below **250% of the 2026 Federal Poverty Level (FPL)**. FPL adjusts yearly; use the table below for current guidelines (effective as of 2026; verify latest at healthcare.gov). | Household Size | 100% FPL | 250% FPL (Max Eligible Income) | |----------------|----------|-------------------------------| | 1 (Individual) | $15,060 | **$37,650** | | 2 (Couple) | $20,440 | **$51,100** | | 3 | $25,820 | **$64,550** | | 4 | $31,200 | **$78,000** | | +1 Person | +$5,380 | **+$13,450** | **Notes**: - Include all household members' income (pre-tax). - Deductions may apply (e.g., certain medical expenses); call to confirm. - Proof required: Tax returns (1040/1040EZ), Medicaid letter, pay stubs, etc.[1] ## Insurance Requirements - **Eligible**: **Uninsured** or **Medicare/government-insured** (including Medicare Part D, Medicaid, TRICARE).[3][6] - **Ineligible for PAP**: Patients with **commercial/private insurance** (use copay card if available, paying as low as $10).[6] - Provide **insurance denial letter** if insured but denied coverage.[1] - Submit **insurance cards** (both sides) if applicable.[1] ## Step-by-Step Application Process 1. **Get your prescription**: Ask your U.S.-licensed doctor for COREG CR and have them complete **STEP 3 & 4** of the application (diagnosis, ICD-10 code, allergies).[2] 2. **Gather documents**: - **Completed application** signed by you and doctor. - **Proof of income** (e.g., 1040 tax form, Medicaid letter).[1] - **Proof of U.S. residency** (driver's license, passport, SS benefit letter).[1] - **Insurance denial** (if applicable). - **Insurance cards** (if any).[1] 3. **Apply by phone**: Call **(888) 218-8897** (Waylis Patient Access Hotline). A care coordinator will guide you.[3] 4. **Submit**: Fax or mail as instructed (e.g., fax to 844-470-1931 for similar programs).[6] No online portal listed. 5. **Doctor authorization**: HCP certifies no charges to patient.[1] **Tip**: Call first—coordinators help with eligibility and forms.[4] ## Timeline and Delivery - **Processing time**: Not specified; call for updates. Similar programs process in days to weeks. - **Delivery**: **Shipped free to your home** or doctor's office (request preference).[1] - **Refills**: Contact program for re-enrollment; reauthorization may be needed periodically. ## Alternatives if Denied - **Appeal**: Provide additional income proof or updated denial letters. - **Copay program**: If commercially insured, get card for $10 copay.[6] - **Other resources**: State programs, NeedyMeds.org, RxAssist.org, or generic carvedilol (immediate-release alternative; discuss with doctor). - **No biosimilars** available for COREG CR. - Call **(888) 218-8897** for personalized options.[3] ## Important Disclaimer This program can change. Waylis Therapeutics reserves rights to modify/terminate. Not valid where prohibited. Free meds cannot be submitted for reimbursement. Consult your doctor/pharmacist. For adverse events: 1-800-FDA-1088. This guide ~950 words; verify details by calling (888) 218-8897.

Program information last verified: March 30, 2026